华润双鹤：关于控股子公司湖南省湘中制药有限公司奥卡西平片获得药品注册证书的公告

Core Viewpoint - China Resources Double Crane Pharmaceutical Co., Ltd. has received a drug registration certificate for Oxcarbazepine tablets from the National Medical Products Administration, indicating a significant regulatory milestone for the company [2]. Group 1 - The announcement was made on the evening of November 18, highlighting the company's progress in drug registration [2]. - The drug registration certificate was issued to Hunan Xiangzhong Pharmaceutical Co., Ltd., a subsidiary of China Resources Double Crane [2].